Pfizer Halts Pursuit Of Zyvox Indication Based On Mortality Signal
Executive Summary
Pfizer will not pursue an indication for catheter-related infections for Zyvox (linezolid) after data from a Phase III trial indicated an increased risk of death among patients with the infections treated with the oxazolidinone antibiotic